Half of Teenage Marijuana Users Now Meet the Criteria for Addiction

Young woman surrounded by green foliage exhaling smoke from a hand-rolled joint, illustrating concerns about teen marijuana addiction.

New federal survey data have delivered a sobering picture of teen marijuana addiction in the United States. More than half of young people who used the drug in the past year now meet clinical criteria for a use disorder.

The figures come from the 2025 National Survey on Drug Use and Health. It was conducted by the Substance Abuse and Mental Health Services Administration and highlighted this month by The Drug Report in its Friday Fact series. Among past year marijuana users aged 12 to 17, 50.3 per cent had a marijuana use disorder. That is roughly 1.1 million adolescents. Teen marijuana addiction is therefore no longer a fringe concern. It has become a defining feature of youth substance use in America today.

The Scale of the Problem

The adolescent figures sit within a much larger national trend. Across all age groups from 12 and older, an estimated 61.6 million Americans used marijuana in the past year. Of those, 19.3 million, or 31.4 per cent, had a marijuana use disorder. Almost one in three adult users already meets that threshold. Even so, the rate among children and teenagers climbs to more than one in two.

This gap between adult and adolescent rates points to an uncomfortable truth. Younger brains appear far more susceptible to developing dependence once regular use begins. Teen marijuana addiction is not simply a smaller version of the adult problem. Instead, it is a distinct and more severe pattern. It develops earlier, and it grips harder.

Why Young Users Are So Vulnerable

Adolescence is a period of rapid brain development. Repeated exposure to THC during these years appears to leave a lasting mark. The developing brain is still building the pathways it will rely on for decision making, memory and impulse control. Cannabis use during this window is thought to disrupt that process. As a result, adolescent marijuana use disorder becomes more likely to take hold, and it is harder to shake off once it does.

These changes often happen quietly and gradually. Families, and even young people themselves, may not recognise the warning signs until use has become entrenched. For this reason, early and consistent prevention messaging aimed squarely at this age group matters far more than intervention after the fact.

An Industry Feeding the Problem

Behind these numbers sits a profit driven marijuana industry. It keeps producing and marketing increasingly potent THC products. Today’s cannabis bears little resemblance to that of previous decades. Concentration levels now far exceed what was typical even ten years ago. As commercial operators compete for market share, stronger and more appealing products continue reaching young consumers. Often, this happens through packaging and flavours with obvious appeal to teenagers.

The result is a feedback loop. Higher potency products increase the likelihood of dependence. Meanwhile, rising teen marijuana addiction creates a larger customer base for an industry with every financial incentive to keep supply flowing. The millions of adolescents already living with a use disorder now face a substance far more potent than the one older generations encountered at the same age.

What the Numbers Mean Going Forward

These statistics send a clear signal. Adolescent marijuana use disorder deserves urgent, sustained attention rather than periodic alarm. A generation of young Americans is developing dependence at rates that outstrip adults, and this is happening during years when their brains are least equipped to absorb the impact.

Addressing this will require consistent education and honest conversations about risk. It will also require a willingness to hold the commercial cannabis industry accountable for how its products reach and affect children. The scale revealed by this survey, more than 1.1 million adolescents living with a marijuana use disorder, leaves little room for complacency.

Source: thedrugreport

Leave a Reply

Your email address will not be published.